These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17542459)

  • 1. Novel Models of Hepatitis C Virus Care Delivery: Telemedicine, Project ECHO, and Integrative Care.
    Arora S; Thornton K
    Clin Liver Dis (Hoboken); 2020 Jul; 16(1):5-7. PubMed ID: 32714515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of health status in patients with hepatitis c treated with and without interferon.
    Ragusa R; Bertino G; Bruno A; Frazzetto E; Cicciu F; Giorgianni G; Lupo L
    Health Qual Life Outcomes; 2018 Jan; 16(1):17. PubMed ID: 29343250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan.
    Capileno YA; Van den Bergh R; Donchunk D; Hinderaker SG; Hamid S; Auat R; Khalid GG; Fatima R; Yaqoob A; Van Overloop C
    PLoS One; 2017; 12(4):e0175562. PubMed ID: 28448576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care?: a narrative systematic review of the evidence base.
    Brew IF; Butt C; Wright N
    Br J Gen Pract; 2013 Dec; 63(617):e842-51. PubMed ID: 24351500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons for Nonattendance across the Hepatitis C Disease Course.
    Butt G; McGuinness L; Buller-Taylor T; Mitchell S
    ISRN Nurs; 2013; 2013():579529. PubMed ID: 24109517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis C infection among current and former injection drug users within a multidisciplinary treatment model at a community health centre.
    Newman AI; Beckstead S; Beking D; Finch S; Knorr T; Lynch C; MacKenzie M; Mayer D; Melles B; Shore R
    Can J Gastroenterol; 2013 Apr; 27(4):217-23. PubMed ID: 23616960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, attitudes and practices among people with chronic hepatitis B attending a hepatology clinic in Malaysia: a cross sectional study.
    Mohamed R; Ng CJ; Tong WT; Abidin SZ; Wong LP; Low WY
    BMC Public Health; 2012 Aug; 12():601. PubMed ID: 22856889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health.
    Buffington J; Jones TS
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):1-5. PubMed ID: 17542445
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?].
    Larrey D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B283-90. PubMed ID: 12180302
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic hepatitis C. Treatment and side effect management.
    Lee SP
    Adv Nurse Pract; 2003 Jul; 11(7):73-8. PubMed ID: 12886741
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing chronic hepatitis C in primary-care settings: more than antiviral therapy.
    Zevin B
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):78-82. PubMed ID: 17542459
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic recommendations for 2013: antiviral treatment for chronic hepatitis B.
    Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Małkowski P; Pawłowska M; Simon K;
    Przegl Epidemiol; 2013; 67(2):287-95, 383-91. PubMed ID: 24040735
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection].
    Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Małkowski P; Pawłowska M; Simon K;
    Przegl Epidemiol; 2010; 64(1):81-2. PubMed ID: 20499665
    [No Abstract]   [Full Text] [Related]  

  • 14. [Polish Experts Group on HBV. Therapeutic recommendations on 2008 year (antiretroviral treatment of chronic hepatitis B)].
    Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Małkowski P; Pawłowska M; Simon K
    Przegl Epidemiol; 2008; 62(2):379-81. PubMed ID: 18807484
    [No Abstract]   [Full Text] [Related]  

  • 15. Perceived barriers to hepatitis C therapy for patients receiving opioid agonist treatment.
    Zickmund SL; Campbell SA; Tirado CF; Zook CL; Weinrieb RM
    J Addict Med; 2012 Sep; 6(3):233-9. PubMed ID: 22790464
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.